Examples of 'pimecrolimus' in a sentence
Meaning of "pimecrolimus"
A medication used to treat eczema, by reducing inflammation and itchiness of the skin
Show more definitions
- An immunomodulating agent used in the treatment of atopic dermatitis.
How to use "pimecrolimus" in a sentence
Basic
Advanced
pimecrolimus
No metabolism of pimecrolimus was observed in human skin in vitro.
Some drugs in this class are tacrolimus and pimecrolimus.
Pimecrolimus caused a similar rate of adverse events to tacrolimus.
There are numerous publications on the efficacy of tacrolimus or pimecrolimus.
Pimecrolimus belongs to the group of macrolactam derivatives of ascomycin.
Systemic exposure is limited with the topical use of pimecrolimus.
The pimecrolimus used contains impurities.
Lymphoma have been reported in patients treated with pimecrolimus cream.
Pimecrolimus cream should not be used in immunocompromised adults or children.
Tacrolimus seemed better tolerated and more effective than pimecrolimus.
Pimecrolimus is an ascomycin macrolactam derivative.
The present invention regards a chemoenzymatic synthesis method for preparing pimecrolimus.
Pimecrolimus must be administered under the supervision of a medical practitioner.
Such method represents the first example of chemoenzymatic synthesis for preparing pimecrolimus.
Therefore pimecrolimus metabolism could not be determined after topical administration.
See also
Excema topicals are also used such as Tacrolimus ointment or pimecrolimus cream.
Topical pimecrolimus is also used and has fewer side effects.
Immune Modulating Medications such as tacrolimus and pimecrolimus.
It is not known whether pimecrolimus is excreted in the milk after topical application.
A chemo-enzymatic approach to the synthesis of pimecrolimus.
Tacrolimus and pimecrolimus are both calcineurin inhibitors and function as immunosuppressants.
Amended, for medicinal products containing topical pimecrolimus.
Ointments containing pimecrolimus or tacrolimus may be more effective with fewer side effects.
Treatment with topical halometasone cream, pimecrolimus cream.
Pimecrolimus was also associated with significantly more overall withdrawals and skin burning.
The Committee considered that pimecrolimus cream is effective in the treatment of mild or.
Pimecrolimus is a calcineurin inhibitor approved as cream formulation at a 1 % concentration.
If you are hypersensitive ( allergic ) to pimecrolimus or any of the other ingredients of.
Pimecrolimus is an immunomodulating agent used in the treatment of atopic dermatitis ( eczema ).
Other topical treatments, tacrolimus or pimecrolimus can also be used.
Use of pimecrolimus in the EU vs US.
Objectives, to assess the effects of topical pimecrolimus for treating eczema.
A statement that pimecrolimus cream should not be used in children under 2 years.
There is no link to increased risk of cancer from topical use of 1 % pimecrolimus cream.
The use of topical tacrolimus and pimecrolimus to treat psoriasis, a review.
In conclusion, pimecrolimus has a skin-selective pharmacological profile different from corticosteroids.
Clinical efficiencies of immunosuppressors like tacrolimus or pimecrolimus have been established by many studies,.
Less than 1 % of the radioactivity found in the feces was due to unchanged pimecrolimus.
The most common side-effect of pimecrolimus is a burning sensation at the application site.
Use of the compound according to claim 9, as a reaction intermediate in the synthesis of pimecrolimus.
Immunosuppressants such as tacrolimus and particularly pimecrolimus in the case of inflammatory skin disease ;.
The chemical / physical characteristics of the obtained product matches the data indicated in literature for pimecrolimus.
The MAHs should measure the off-label use of pimecrolimus in patients of less than 2 years.
Pimecrolimus is reportedly used as an immunosuppressant . Id.
Overall summary of the scientific evaluation of medicinal products containing pimecrolimus ( see annex i ).
Positive control Pimecrolimus which is a known inhibitor of IL2 inhibited at all the concentrations tested.
The immunomodulators that may be used in combination are advantageously tacrolimus, pimecrolimus and oxazolines.
Thus pimecrolimus inhibits T-cell activation by inhibiting the synthesis and release of cytokines from T-cells.
The immunomodulators that can be used in combination are advantageously tacrolimus, pimecrolimus and oxazolines.
Pimecrolimus 1 % is also an immunomodulator and calcineurin inhibitor.
